Ekso Bionics Ownership 2024 | Who Owns Ekso Bionics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

11.34%

Insider Ownership

8.84%

Retail Ownership

79.82%

Institutional Holders

28.00

Ekso Bionics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
KENT LAKE CAPITAL LLC4.00%0.33%696,050100,00016.78%734,333Jun 30, 2024
VANGUARD GROUP INC3.41%-594,42723,2724.07%627,120Jun 30, 2024
CRESSET ASSET MANAGEMENT, LLC1.72%0.00%300,000300,000100.00%316,500Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.78%-135,82325,47423.08%143,343Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.43%0.00%75,516-6,200-7.59%79,669Jun 30, 2024
BLACKROCK INC.0.31%-54,749--57,760Jun 30, 2024
COMPAGNIE LOMBARD ODIER SCMA0.14%0.00%25,000--26,375Jun 30, 2024
NORTHERN TRUST CORP0.14%-24,850-23-0.09%26,217,000Jun 30, 2024
STATE STREET CORP0.13%-23,180--24,455,000Jun 30, 2024
XTX TOPCO LTD0.12%0.00%21,44921,449100.00%22,629Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.0.07%0.00%12,6676505.41%13,364Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.03%0.00%4,462-929-17.23%4,707Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-3,181-2,002-38.63%3,370Jun 30, 2024
UBS GROUP AG0.01%-1,717-5,562-76.41%1,811Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.00%-458--483Jun 30, 2024
TRADEWINDS CAPITAL MANAGEMENT, LLC0.00%0.00%260--275Jun 30, 2024
NEWEDGE ADVISORS, LLC0.00%-200--211Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-155127453.57%164Jun 30, 2024
MORGAN STANLEY0.00%-129-300-69.93%136Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-64--79Jun 30, 2024

Ekso Bionics's largest institutional shareholder is KENT LAKE CAPITAL LLC, holding 4.00% of the company's total share outstanding, currently valued at $734.33K. The top 10 institutional shareholders own together 11.20% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
KENT LAKE CAPITAL LLC4.00%0.33%696,050100,00016.78%734,333Jun 30, 2024
XTX TOPCO LTD0.12%0.00%21,44921,449100.00%22,629Jun 30, 2024
CRESSET ASSET MANAGEMENT, LLC1.72%0.00%300,000300,000100.00%316,500Jun 30, 2024
COMPAGNIE LOMBARD ODIER SCMA0.14%0.00%25,000--26,375Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.0.07%0.00%12,6676505.41%13,364Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.43%0.00%75,516-6,200-7.59%79,669Jun 30, 2024
TRADEWINDS CAPITAL MANAGEMENT, LLC0.00%0.00%260--275Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.03%0.00%4,462-929-17.23%4,707Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.00%-458--483Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.78%-135,82325,47423.08%143,343Jun 30, 2024
VANGUARD GROUP INC3.41%-594,42723,2724.07%627,120Jun 30, 2024
FRONT ROW ADVISORS LLC0.00%-31--33Jun 30, 2024
WR WEALTH PLANNERS, LLC0.00%-29--31Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-3,181-2,002-38.63%3,370Jun 30, 2024
EUKLES ASSET MANAGEMENT0.00%-13--14Jun 30, 2024
NORTHERN TRUST CORP0.14%-24,850-23-0.09%26,217,000Jun 30, 2024
VOISARD ASSET MANAGEMENT GROUP, INC.--4--5Jun 30, 2024
NEWEDGE ADVISORS, LLC0.00%-200--211Jun 30, 2024
BLACKROCK INC.0.31%-54,749--57,760Jun 30, 2024
STATE STREET CORP0.13%-23,180--24,455,000Jun 30, 2024

The largest Ekso Bionics shareholder by % of total assets is KENT LAKE CAPITAL LLC. The company owns 696.05K shares of Ekso Bionics (EKSO), representing 0.33% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CRESSET ASSET MANAGEMENT, LLC1.72%0.00%300,000300,000100.00%316,500Jun 30, 2024
KENT LAKE CAPITAL LLC4.00%0.33%696,050100,00016.78%734,333Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.78%-135,82325,47423.08%143,343Jun 30, 2024
VANGUARD GROUP INC3.41%-594,42723,2724.07%627,120Jun 30, 2024
XTX TOPCO LTD0.12%0.00%21,44921,449100.00%22,629Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.0.07%0.00%12,6676505.41%13,364Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-155127453.57%164Jun 30, 2024
JPMORGAN CHASE & CO0.00%-3838.57%40Jun 30, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.00%-26--27Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-64--79Jun 30, 2024
STATE STREET CORP0.13%-23,180--24,455,000Jun 30, 2024
BLACKROCK INC.0.31%-54,749--57,760Jun 30, 2024
NEWEDGE ADVISORS, LLC0.00%-200--211Jun 30, 2024
VOISARD ASSET MANAGEMENT GROUP, INC.--4--5Jun 30, 2024
EUKLES ASSET MANAGEMENT0.00%-13--14Jun 30, 2024
WR WEALTH PLANNERS, LLC0.00%-29--31Jun 30, 2024
FRONT ROW ADVISORS LLC0.00%-31--33Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.00%-458--483Jun 30, 2024
TRADEWINDS CAPITAL MANAGEMENT, LLC0.00%0.00%260--275Jun 30, 2024
COMPAGNIE LOMBARD ODIER SCMA0.14%0.00%25,000--26,375Jun 30, 2024

As of Jun 30 2024, Ekso Bionics's largest institutional buyer is CRESSET ASSET MANAGEMENT, LLC. The company purchased 300.00K stocks of EKSO, valued at $316.50K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DIMENSIONAL FUND ADVISORS LP----10,456-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.43%0.00%75,516-6,200-7.59%79,669Jun 30, 2024
UBS GROUP AG0.01%-1,717-5,562-76.41%1,811Jun 30, 2024
SIMPLEX TRADING, LLC----2,257-100.00%-Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-3,181-2,002-38.63%3,370Jun 30, 2024
GROUP ONE TRADING, L.P.----2,000-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.03%0.00%4,462-929-17.23%4,707Jun 30, 2024
MORGAN STANLEY0.00%-129-300-69.93%136Jun 30, 2024
ICA GROUP WEALTH MANAGEMENT, LLC----149-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----121-100.00%-Jun 30, 2024
FMR LLC----80-100.00%-Jun 30, 2024
OPEROSE ADVISORS LLC----74-100.00%-Jun 30, 2024
ALBION FINANCIAL GROUP /UT----67-100.00%-Jun 30, 2024
NORTHERN TRUST CORP0.14%-24,850-23-0.09%26,217,000Jun 30, 2024
AVION WEALTH----4-100.00%-Jun 30, 2024
COMPAGNIE LOMBARD ODIER SCMA0.14%0.00%25,000--26,375Jun 30, 2024
TRADEWINDS CAPITAL MANAGEMENT, LLC0.00%0.00%260--275Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.00%-458--483Jun 30, 2024
FRONT ROW ADVISORS LLC0.00%-31--33Jun 30, 2024
WR WEALTH PLANNERS, LLC0.00%-29--31Jun 30, 2024

As of Jun 30 2024, Ekso Bionics's biggest institutional seller is DIMENSIONAL FUND ADVISORS LP. The company sold -10.46K shares of EKSO, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CRESSET ASSET MANAGEMENT, LLC1.72%0.00%300,000300,000100.00%316,500Jun 30, 2024

Ekso Bionics's largest new institutional shareholder by number of shares is CRESSET ASSET MANAGEMENT, LLC, purchased 300.00K shares, valued at $316.50K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DIMENSIONAL FUND ADVISORS LP----10,456-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----2,257-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----2,000-100.00%-Jun 30, 2024
ICA GROUP WEALTH MANAGEMENT, LLC----149-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----121-100.00%-Jun 30, 2024
FMR LLC----80-100.00%-Jun 30, 2024
OPEROSE ADVISORS LLC----74-100.00%-Jun 30, 2024
ALBION FINANCIAL GROUP /UT----67-100.00%-Jun 30, 2024
AVION WEALTH----4-100.00%-Jun 30, 2024

Ekso Bionics's largest sold out institutional shareholder by shares sold is DIMENSIONAL FUND ADVISORS LP, sold -10.46K shares, valued at -, as of undefined.

Ekso Bionics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
NEXPOINT FUNDS I0.01%38,135--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%2,058,750--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%382,393--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%552,431-49,864-8.28%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%34,612--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%21,090--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%103,02211,42712.48%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%14,085--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%8,363--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%1,406--Feb 29, 2024
Dimensional ETF Trust0.00%4,709--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%8,773--Jan 31, 2024
EQ ADVISORS TRUST0.00%9,864--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%1,316--Jan 31, 2024
EQ ADVISORS TRUST0.00%2,652--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%4,330--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%534--Mar 31, 2024

Ekso Bionics's largest mutual fund holder by % of total assets is "NEXPOINT FUNDS I", owning 38.13K shares, compromising 0.01% of its total assets.

Ekso Bionics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2428-24.32%
31 Mar, 24375.71%
31 Dec, 2335-2.78%
30 Sep, 233612.50%
30 Jun, 2332-3.03%
31 Mar, 23336.45%
31 Dec, 223119.23%
30 Sep, 2226-10.34%
30 Jun, 22297.41%
31 Mar, 2227-10.00%
31 Dec, 2130-3.23%
30 Sep, 2131-6.06%
30 Jun, 21336.45%
31 Mar, 213193.75%
31 Dec, 2016-15.79%
30 Sep, 2019-20.83%
30 Jun, 202484.62%
31 Mar, 2013-

As of 30 Jun 24, 28 institutions are holding Ekso Bionics's shares, representing a decrease of -24.32% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,974,47828.73%
31 Mar, 241,533,77133.41%
31 Dec, 231,149,6343.31%
30 Sep, 231,112,812-15.51%
30 Jun, 231,317,053-0.56%
31 Mar, 231,324,534-7.64%
31 Dec, 221,434,034-14.28%
30 Sep, 221,672,8444.31%
30 Jun, 221,603,68211.45%
31 Mar, 221,438,965-22.81%
31 Dec, 211,864,22646.66%
30 Sep, 211,271,1150.83%
30 Jun, 211,260,649-0.51%
31 Mar, 211,267,127300.48%
31 Dec, 20316,402-77.96%
30 Sep, 201,435,29827.22%
30 Jun, 201,128,1669.50%
31 Mar, 201,030,320-

Ekso Bionics (EKSO) has 1.97M shares outstanding as of 30 Jun 24, up 28.73% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2411.34%10.06%
31 Mar, 2410.62%15.91%
31 Dec, 238.17%12.27%
30 Sep, 238.16%8.32%
30 Jun, 239.91%9.98%
31 Mar, 239.96%8.39%
31 Dec, 2210.90%6.65%
30 Sep, 2212.80%8.26%
30 Jun, 2212.45%9.74%
31 Mar, 2211.31%4.84%
31 Dec, 2115.29%15.17%
30 Sep, 2110.04%10.12%
30 Jun, 219.96%7.17%
31 Mar, 2111.79%60.42%
31 Dec, 204.42%1.45%
30 Sep, 2017.43%5.37%
30 Jun, 2018.02%5.72%
31 Mar, 2017.75%-

As of 30 Jun 24, Ekso Bionics is held by 11.34% institutional shareholders, representing a 10.06% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 248-55.56%
31 Mar, 241812.50%
31 Dec, 231645.45%
30 Sep, 231183.33%
30 Jun, 236-25.00%
31 Mar, 238-52.94%
31 Dec, 221788.89%
30 Sep, 229-25.00%
30 Jun, 221220.00%
31 Mar, 2210-16.67%
31 Dec, 211220.00%
30 Sep, 2110-28.57%
30 Jun, 2114-41.67%
31 Mar, 2124242.86%
31 Dec, 207-41.67%
30 Sep, 2012-40.00%
30 Jun, 202053.85%
31 Mar, 2013-

8 institutional shareholders have increased their position in EKSO stock as of 30 Jun 24 compared to 18 in the previous quarter (a -55.56% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 247-
31 Mar, 247250.00%
31 Dec, 232-75.00%
30 Sep, 238100.00%
30 Jun, 234-42.86%
31 Mar, 23740.00%
31 Dec, 225-16.67%
30 Sep, 22620.00%
30 Jun, 225-28.57%
31 Mar, 227-12.50%
31 Dec, 218-
30 Sep, 21833.33%
30 Jun, 21650.00%
31 Mar, 214-33.33%
31 Dec, 206200.00%
30 Sep, 202-
30 Jun, 202-
31 Mar, 20--

7 institutional shareholders have reduced their position in EKSO stock as of 30 Jun 24 compared to 7 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2428-24.32%1,974,47828.73%11.34%10.06%8-55.56%7-
31 Mar, 24375.71%1,533,77133.41%10.62%15.91%1812.50%7250.00%
31 Dec, 2335-2.78%1,149,6343.31%8.17%12.27%1645.45%2-75.00%
30 Sep, 233612.50%1,112,812-15.51%8.16%8.32%1183.33%8100.00%
30 Jun, 2332-3.03%1,317,053-0.56%9.91%9.98%6-25.00%4-42.86%
31 Mar, 23336.45%1,324,534-7.64%9.96%8.39%8-52.94%740.00%
31 Dec, 223119.23%1,434,034-14.28%10.90%6.65%1788.89%5-16.67%
30 Sep, 2226-10.34%1,672,8444.31%12.80%8.26%9-25.00%620.00%
30 Jun, 22297.41%1,603,68211.45%12.45%9.74%1220.00%5-28.57%
31 Mar, 2227-10.00%1,438,965-22.81%11.31%4.84%10-16.67%7-12.50%
31 Dec, 2130-3.23%1,864,22646.66%15.29%15.17%1220.00%8-
30 Sep, 2131-6.06%1,271,1150.83%10.04%10.12%10-28.57%833.33%
30 Jun, 21336.45%1,260,649-0.51%9.96%7.17%14-41.67%650.00%
31 Mar, 213193.75%1,267,127300.48%11.79%60.42%24242.86%4-33.33%
31 Dec, 2016-15.79%316,402-77.96%4.42%1.45%7-41.67%6200.00%
30 Sep, 2019-20.83%1,435,29827.22%17.43%5.37%12-40.00%2-
30 Jun, 202484.62%1,128,1669.50%18.02%5.72%2053.85%2-
31 Mar, 2013-1,030,320-17.75%-13---

Ekso Bionics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy4,032$1.24$5.00K147,990
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy5,500$0.95$5.22K143,958
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy4,201$1.25$5.25K138,458
Aug 18, 2023Davis Scott G.officer President & COOS-SaleSell37,446$1.00$37.28K331,372
Aug 18, 2023Wong Jeromeofficer Chief Financial OfficerS-SaleSell12,784$1.00$12.73K266,953

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy4,032$1.24$5.00K147,990
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy5,500$0.95$5.22K143,958
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy4,201$1.25$5.25K138,458

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 18, 2023Davis Scott G.officer President & COOS-SaleSell37,446$1.00$37.28K331,372
Aug 18, 2023Wong Jeromeofficer Chief Financial OfficerS-SaleSell12,784$1.00$12.73K266,953

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 26, 2024Cloyd Mary Anndirector-A-AwardBuy78,217--220,505
Jun 26, 2024Lathan Corinnadirector-A-AwardBuy78,217--226,207
Jun 26, 2024Li Kechengdirector-A-AwardBuy78,217--224,738
Jun 26, 2024Scher Deborah Laferdirector-A-AwardBuy78,217--78,217
Jun 14, 2024Scher Deborah Laferdirector Buy----
Apr 04, 2024Wong Jeromeofficer Chief Financial OfficerA-AwardBuy7,474--18,887
Apr 04, 2024Jones Jason Cofficer Chief Operating OfficerA-AwardBuy7,474--22,865
Apr 04, 2024Jones Jason Cofficer Chief Operating OfficerA-AwardBuy10,800--15,391
Apr 04, 2024Jones Jason Cofficer Chief Operating OfficerA-AwardBuy3,446--4,591
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy4,032$1.24$5.00K147,990
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy5,500$0.95$5.22K143,958
Mar 14, 2024Lathan Corinnadirector-P-PurchaseBuy4,201$1.25$5.25K138,458
Aug 18, 2023Davis Scott G.officer President & COOS-SaleSell37,446$1.00$37.28K331,372
Aug 18, 2023Wong Jeromeofficer Chief Financial OfficerS-SaleSell12,784$1.00$12.73K266,953
Jun 27, 2023Cloyd Mary Anndirector-A-AwardBuy67,392--142,288
Jun 27, 2023Lathan Corinnadirector-A-AwardBuy67,392--134,257
Jun 27, 2023Wallen Rhonda A.director-A-AwardBuy67,392--142,288
Jun 27, 2023Li Kechengdirector-A-AwardBuy67,392--146,521
Jun 27, 2023SHERMAN STEVENofficer Executive ChairA-AwardBuy84,240--449,153
Jun 16, 2023Cloyd Mary Anndirector-A-AwardBuy72,993--147,889

The last insider sell of Ekso Bionics's stock was made by Davis Scott G. on Aug 18 2023, selling 37,446 shares at $1.00 per share (valued at $37.28K). The last insider buy of EKSO was made by Lathan Corinna on Mar 14 2024, buying 4,032 shares at $1.24 per share (worth $5.00K).

Ekso Bionics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-2-
Q2 2023152750.00%
Q4 20226875.00%
Q3 2022-7-
Q2 202281266.67%
Q1 202287114.29%
Q4 202111100.00%
Q3 20213--
Q2 20215--
Q1 20217--
Q4 2020-1-
Q3 20205--
Q2 20204--
Q1 2020122600.00%
Q4 20194--
Q2 20193560.00%
Q4 20182--
Q3 2018102500.00%
Q2 201844100.00%
Q1 201844100.00%

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Ekso Bionics's insiders, as of Q3 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-2-
Q2 2023-2-
Q4 2022-5-
Q3 2022-5-
Q2 2022-6-
Q1 2022-4-
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021---
Q4 2020---
Q3 2020---
Q2 2020---
Q1 2020---
Q4 2019---
Q2 2019-3-
Q4 2018---
Q3 2018---
Q2 20182--
Q1 2018---

As of Q3 2023, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Ekso Bionics's stocks.

Ekso Bionics Peer Ownership


TickerCompany
NEPHNephros, Inc.
FEMYFemasys Inc.
GMVDG Medical Innovations Holdings Ltd
AKYAAkoya Biosciences, Inc.
GCTKGlucoTrack, Inc.
ATRIAtrion Corporation
POCIPrecision Optics Corporation, Inc.
LMATLeMaitre Vascular, Inc.
UTMDUtah Medical Products, Inc.
PDEXPro-Dex, Inc.

EKSO Ownership FAQ


Ekso Bionics is owned by institutional shareholders (11.34%), insiders (8.84%), and public (79.82%). The largest institutional shareholder of Ekso Bionics is KENT LAKE CAPITAL LLC (4.00% of total shares) and the top mutual fund owner is NEXPOINT FUNDS I (0.01% of total shares).

Ekso Bionics's major institutional shareholders are KENT LAKE CAPITAL LLC, VANGUARD GROUP INC, CRESSET ASSET MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC. The top five shareholders own together 10.34% of the company's share outstanding.

As of Jun 2024, there are 28 institutional shareholders of Ekso Bionics.

KENT LAKE CAPITAL LLC owns 696.05K shares of Ekso Bionics, representing 4.00% of the company's total shares outstanding, valued at $734.33K (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 594.43K shares of Ekso Bionics (EKSO), compromising 3.41% of the company, valued at $627.12K.

CRESSET ASSET MANAGEMENT, LLC is the third largest holder of Ekso Bionics. The company owns 300K of the company's shares outstanding (worth $316.5K).